+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "RNA"

Gene therapy - Lipid nanoparticles - Product Thumbnail Image

Gene therapy - Lipid nanoparticles

  • Report
  • August 2024
  • 41 Pages
  • Global
From
From
From
Genomic Data Analysis and Interpretation Market - Product Thumbnail Image

Genomic Data Analysis and Interpretation Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
From
Latin America Gene Expression Market Report and Forecast 2024-2032 - Product Thumbnail Image

Latin America Gene Expression Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Latin America
From
Asia Pacific Gene Expression Market Report and Forecast 2024-2032 - Product Thumbnail Image

Asia Pacific Gene Expression Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Asia Pacific
From
Europe Gene Expression Market Report and Forecast 2024-2032 - Product Thumbnail Image

Europe Gene Expression Market Report and Forecast 2024-2032

  • Report
  • June 2024
  • 140 Pages
  • Europe
From
From
Loading Indicator

The RNA market is a subset of the genomics market that focuses on the study of ribonucleic acid (RNA). RNA is a molecule that plays a key role in the regulation of gene expression and is involved in many cellular processes. It is used in a variety of applications, including diagnostics, therapeutics, and research. The RNA market is expected to grow at a steady rate due to the increasing demand for RNA-based products and services. This growth is driven by advances in technology, such as next-generation sequencing, which has enabled the development of more accurate and cost-effective RNA-based products. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine are expected to drive the growth of the RNA market. Companies in the RNA market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, Bio-Rad Laboratories, and F. Hoffmann-La Roche. Show Less Read more